Pharmaceutical Executive

By Pharmaceutical Executive PodcastScience Life Sciences

Pharmaceutical Executive episodes

September 08, 2025 Pharmaceutical Executive Daily: September 8, 2025
3 min
September 05, 2025 Pharmaceutical Executive Daily: September 5, 2025
In today’s Pharmaceutical Executive Daily, we will recap the top stories of the week, exploring the current state of the GLP-1 market, review major pharmaceutical layoffs shaping 2025, and cover Pfizer’s response to political pressure on COVID-19 vaccine safety evidence.
3 min
September 04, 2025 Pharmaceutical Executive Daily: September 4, 2025
In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into the evolving GLP-1 market, and Sanofi’s share decline following disappointing Phase III results for Amlitelimab.
3 min
September 03, 2025 Pharmaceutical Executive Daily: September 3, 2025
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s outlook on future GLP-1 investment, and Novartis’ $5.2 billion acquisition of Argo Biopharmaceuticals.
3 min
August 22, 2025 The Rx for High-Performance Leadership: Cutting Through the Chaos
In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who shape the industry’s future.
15 min
August 21, 2025 Pharmaceutical Executive Weekly:CSL Cuts Jobs, Pfizer’s Sickle Cell Setback, and Eli Lilly Expands Zepbound Access
In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s Phase 3 trial failure in sickle cell disease, and Eli Lilly’s new LillyDirect program expanding full-dose Zepbound access for obesity patients.
3 min
April 14, 2025 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced investigator diversity through educational sessions and multilingual toolkits, and how Takeda aims to expand these efforts globally.
18 min
March 24, 2025Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:
The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.
How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts
The importance of telehealth in ensuring medication availability
Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
and more
18 min
March 11, 2025The Misinformation Maze: Navigating Public Health in the Digital Age
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses:
The threat of misinformation to public health and how emotional appeal plays a part
Where patients are turning for trustworthy health information
Strategies that can be used to verify information
Pharma's role in helping to ensure patients have access to health insights they can trust
Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients
What kind of role regulatory agencies should play in the battle against misinformation
and much more!
Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025
25 min
February 18, 2025Navigating Distrust: Pharma in the Age of Social Media
In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss:
The growing distrust in social media
Why people trust friends and influencers over companies
The EMA's departure from X
Concerns about information accessibility
The healthcare industry's trust gap
"Dark Social"
and SO MUCH MORE!
Pharmaceutical Executive has a brand new look! Click through our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025
27 min